Weiping Li

Weiping Li practices at The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD in Needham, Massachusetts.

Weiping Li's NPI, 1932331550, was assigned on August 14, 2009. Weiping Li holds Tennessee license 53939.

Weiping Li's primary practice is The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD, at 148 Chestnut St, Needham, MA 02492.

Weiping Li's primary practice is The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD in Needham, Massachusetts. Weiping Li is also affiliated with Beth Israel Deaconess Hospital-Needham. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Weiping Li to 1 more hospital, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Weiping Li practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Weiping Li's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Weiping Li's licenses on file in 2 states: Tennessee and Delaware.

CMS data shows 1,002 Medicare services from Weiping Li across 4 procedure codes in 2024, for 414 Medicare patients. Medicare paid $78,128 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 414 Medicare patients who saw Weiping Li in 2024. The largest group is 85 and over, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Weiping Li's median patient age at 81, with 58% women.

In 2024, Weiping Li wrote 276 Medicare Part D claims for 153 patients. 87% of them were for generic drugs. CMS names the drug for 119 of them, across 8 drugs with 11 or more claims each, at $7,036 in total drug cost. In 2023, CMS named 23 claims across 2 drugs.

Weiping Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Weiping Li from 6 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $141.